ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1361

Utility of Rheumatoid Arthritis Impact of Disease (RAID) in Routine Care; Identification of Patients Achieving DAS28 Remission or Low Disease Activity, and Burden of Unmet Patient Reported Outcomes

Jatin Mistry 1, Margaret Sibley 2, Catherine Smith 3, Malama Sumbwanyambe 2 and Patrick Kiely2, 1St George's University of London, London, United Kingdom, 2St George's University Hospitals NHS Trust, London, United Kingdom, 3St Georges University Hospitals NHS Foundation Trust, London, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fatigue and das, patient outcomes, raid, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II: Treatments, Outcomes, & Measures

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: ACR/EULAR guidelines recommend remission or low DAS28 as the treat to target goal for patients with rheumatoid arthritis (RA). Alternative patient reported outcomes include the rheumatoid arthritis impact of disease (RAID), a self-reported index which assesses seven domains by visual analogue scale: pain, disability, fatigue, sleep, coping, physical and emotional well-being. Responses are weighted differently, producing a final score from 0-10. A score less than 2 is considered a patient-acceptable status. We have assessed the relation of RAID to (i) DAS28 categories in routine care, (ii) it’s utility to identify patients in DAS28 remission (RDAS) or low disease activity (LDAS) and (iii) the burden of unmet patient needs in those achieving RDAS/LDAS.

Methods: RA patients attending for routine review in the outpatient clinic at St George’s Hospital were assessed. DAS28 CRP and ESR scores were recorded and RAID questionnaires completed by patients and calculated using the on-line EULAR tool. Summary statistics and Spearman correlation coefficient were analysed on Excel and Mann-Whitney U tests using socscistatistics.com.

Results: 219 patients with established RA were assessed, 81.3% female, mean age 58.8 years, 72.1% RF positive and 79.5% ACPA positive. The number of patients per DAS28 CRP category was RDAS (< 2.6) n=119 (54.6%), LDAS (2.6-3.2) n=34 (15.6%), moderate (MDAS 3.21-5.1) n= 60 (27.5%), high (HDAS >5.1) n= 5 (2.3%). RAID scores correlated strongly with patient global (r=0.69), DAS28 CRP (r=0.62) and DAS28 ESR (r=0.55) but poorly with tender joint count (r=0.30), swollen joint count (r=0.14), ESR (r=0.15) and CRP (r=0.09). The mean RAID score per DAS28 CRP category was RDAS 2.14, LDAS 5.23, M+HDAS 6.09. RAID scores were significantly different (Mann-Witney U) between RDAS versus LDAS (p< 0.00001), RDAS versus M+HDAS (p< 0.00001), LDAS versus M+HDAS (p=0.02). Similar significant differences in RAID scores were found between DAS28 ESR categories. Of 66 patients with RAID < 2, DAS28 CRP was < 2.6 in 64 (97%) and < 3.2 in 65 (98.5%). Of 151 patients with DAS28 CRP < 3.2, RAID was >2 in 86 (57%) with fatigue followed by sleep being the worst scoring domains.

Conclusion: In patients with established RA in routine care, RAID strongly correlates with patient global and DAS28, and scores are significantly lower in patients achieving RDAS versus LDAS and either RDAS or LDAS versus M+HDAS. Virtually all patients with a RAID score < 2 are in DAS28 remission or low disease activity defined by DAS28, and this could be used to minimise unnecessary consultations. However, over half of all patients with DAS28 < 3.2 have unacceptable RAID, and fatigue dominates the unmet needs driving this unacceptable state.

Relation between individual patient RAID and DAS28 CRP scores

RAID scores per DAS28 CRP disease activity category


Disclosure: J. Mistry, None; M. Sibley, None; C. Smith, None; M. Sumbwanyambe, None; P. Kiely, None.

To cite this abstract in AMA style:

Mistry J, Sibley M, Smith C, Sumbwanyambe M, Kiely P. Utility of Rheumatoid Arthritis Impact of Disease (RAID) in Routine Care; Identification of Patients Achieving DAS28 Remission or Low Disease Activity, and Burden of Unmet Patient Reported Outcomes [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/utility-of-rheumatoid-arthritis-impact-of-disease-raid-in-routine-care-identification-of-patients-achieving-das28-remission-or-low-disease-activity-and-burden-of-unmet-patient-reported-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-rheumatoid-arthritis-impact-of-disease-raid-in-routine-care-identification-of-patients-achieving-das28-remission-or-low-disease-activity-and-burden-of-unmet-patient-reported-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology